Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Morrison

Showing results (1001-1010 of 1,096) with videos related to

Pageof 110
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 30, 2017
Discovery of imidazo[1,2-a]-, [1,2,4]triazolo[4,3-a]-, and [1,2,4]triazolo[1,5-a]pyridine-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5Andrew S Felts, Alice L Rodriguez, Ryan D Morrison, et al.
The Lancet. Psychiatry|August 1, 2020
Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trialTom P Freeman, Chandni Hindocha, Gianluca Baio, et al.
Plastic and Reconstructive Surgery|December 28, 2017
PHD-2 Suppression in Mesenchymal Stromal Cells Enhances Wound HealingSae Hee Ko, Allison C Nauta, Shane D Morrison, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2011
Development of a more highly selective M(1) antagonist from the continued optimization of the MLPCN Probe ML012Bruce J Melancon, Alexander P Lamers, Thomas M Bridges, et al.
Schizophrenia Bulletin|July 18, 2014
How cannabis causes paranoia: using the intravenous administration of ∆9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoiaDaniel Freeman, Graham Dunn, Robin M Murray, et al.
Eclinicalmedicine|April 23, 2026
Outcome measurement instruments for the core outcome sets on genital gender-affirming surgery: the GenderCOS projectMatteo Angelini, Philippine J Roijer, Marleen S Vallinga, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
FGF21 acts in the brain to drive macronutrient-specific changes in behavioral motivation and brain reward signalingMd Shahjalal H Khan, Sora Q Kim, Robert C Ross, et al.
Journal of Medicinal Chemistry|November 3, 2015
Design of 4-Oxo-1-aryl-1,4-dihydroquinoline-3-carboxamides as Selective Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 2Andrew S Felts, Alice L Rodriguez, Katrina A Smith, et al.
Leukemia|June 8, 2011
Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profilesM G Loudin, J Wang, H-C Eastwood Leung, et al.
BMC Medical Genomics|October 21, 2016
Pitfalls of improperly procured adjacent non-neoplastic tissue for somatic mutation analysis using next-generation sequencingLei Wei, Antonios Papanicolau-Sengos, Song Liu, et al.
Pageof 110

Showing results (1001-1010 of 1,096) with videos related to

Sort By:
Pageof 110
Bioorganic & Medicinal Chemistry Letters|September 30, 2017
Discovery of imidazo[1,2-a]-, [1,2,4]triazolo[4,3-a]-, and [1,2,4]triazolo[1,5-a]pyridine-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5Andrew S Felts, Alice L Rodriguez, Ryan D Morrison, et al.
The Lancet. Psychiatry|August 1, 2020
Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trialTom P Freeman, Chandni Hindocha, Gianluca Baio, et al.
Plastic and Reconstructive Surgery|December 28, 2017
PHD-2 Suppression in Mesenchymal Stromal Cells Enhances Wound HealingSae Hee Ko, Allison C Nauta, Shane D Morrison, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2011
Development of a more highly selective M(1) antagonist from the continued optimization of the MLPCN Probe ML012Bruce J Melancon, Alexander P Lamers, Thomas M Bridges, et al.
Schizophrenia Bulletin|July 18, 2014
How cannabis causes paranoia: using the intravenous administration of ∆9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoiaDaniel Freeman, Graham Dunn, Robin M Murray, et al.
Eclinicalmedicine|April 23, 2026
Outcome measurement instruments for the core outcome sets on genital gender-affirming surgery: the GenderCOS projectMatteo Angelini, Philippine J Roijer, Marleen S Vallinga, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
FGF21 acts in the brain to drive macronutrient-specific changes in behavioral motivation and brain reward signalingMd Shahjalal H Khan, Sora Q Kim, Robert C Ross, et al.
Journal of Medicinal Chemistry|November 3, 2015
Design of 4-Oxo-1-aryl-1,4-dihydroquinoline-3-carboxamides as Selective Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 2Andrew S Felts, Alice L Rodriguez, Katrina A Smith, et al.
Leukemia|June 8, 2011
Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profilesM G Loudin, J Wang, H-C Eastwood Leung, et al.
BMC Medical Genomics|October 21, 2016
Pitfalls of improperly procured adjacent non-neoplastic tissue for somatic mutation analysis using next-generation sequencingLei Wei, Antonios Papanicolau-Sengos, Song Liu, et al.
Pageof 110